Application of 21-Gene test in adjuvant radiotherapy for early breast cancer
Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 3
Abstract
Breast cancer is the most common malignant tumor in women. With the development of genomics technology and medical frontier technology, the systemic treatment of breast cancer has gradually entered the era of personalized medicine. However, the decision-making of adjuvant radiotherapy for breast cancer still mainly relies on traditional clinicopathological factors, and there is a lack of scientific and reliable tools to guide precise radiotherapy in different populations. Hormone receptor (HR) positive/human epidermal growth factor receptor 2 (HER2) negative breast cancer is the most common molecular subtype of breast cancer. The 21-Gene recurrence score (RS) test (Oncotype Dx™, Genomic Health, Redwood City, CA) is a commercially available genomic test for breast cancer. In this article, we reviewed the current research evidence on the use of 21-Gene RS test for radiotherapy decision-making in HR-positive HER2-negative early breast cancer. Current clinical studies support the predictive value of 21-Gene RS test for adjuvant radiotherapy, and several large-scale prospective clinical studies in this area are underway.
Authors and Affiliations
Xiaolu TANG, Xin HUA, Lu CAO, Jiayi CHEN
Relationship between serum PD-L1 levels and prognosis of gastric cancer patients
[Objective] To analyze the serum PD-L1 levels of gastric cancer patients and its relationship with tumor stage and prognosis. [Methods] Serum of sixty patients with pathological diagnosis of gastric cancer in our hospita...
Risk factors and prognosis of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in ICU patients: a report of 81 cases
[Objective] Comprehensive mortality risk analyses and therapeutic assessment in real-world practice are beneficial to guide individual treatment in patients with Carbapenem-resistant Klebsiella pneumoniae bloodstream inf...
Clinical significance of laparoscopic exploration for peritoneal metastatic gastric cancer
Occurrence and treatment of hypertension associated with targeted therapy in hepatocellular carcinoma
Intraperitoneal combined with systemic neoadjuvant chemotherapy for treatment of peritoneal metastatic gastric cancer: clinical significance and key